MS Australia funds a record number of projects targeting MS research priorities
5 March 2025
MS Australia has committed over $5.7 million to a record number of new research grants, all addressing key MS research priorities.
MS Australia has committed over $5.7 million to a record number of new research grants, all addressing key MS research priorities.
MS Australia is inviting Australians with MS, their friends, family, carers, doctors, MS staff, nurses, researchers, and the broader MS community to join in the discussion to share which areas of MS research and advocacy are most important to people both directly and indirectly affected by MS.
As we barrel towards another election, CEO Rohan Greenland urges politicians to back MS Australia’s three priorities to improve the lives of people living with MS and pave the way to cures.
Launching in mid-2025, the new Australian MS app InforMS is designed to help people manage their MS, creating a “one-stop shop” to hold their health information. People living with MS explain how lived experience has shaped its design.
An updated resource has been released to guide healthcare professionals on the best ways to care for people with MS in Australia and New Zealand.
The Pharmaceutical Benefits Advisory Committee (PBAC) will consider ublituximab (Briumvi®) for treating relapsing remitting MS at their May 2025 meeting.
Bunbury local Lynda Whitton, a dedicated champion for people living with multiple sclerosis (MS), has been awarded MS Australia’s highest honour, the 2024 John Studdy Award.
Tamworth’s Marianne Gaul AM, an acclaimed nurse and dedicated volunteer, has been awarded the 2024 MS Advocate Award by MS Australia.
Newcastle’s Professor Jeannette Lechner-Scott, an internationally recognised neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.